Kallikrein-Related Peptidase 7 Promotes Multicellular Aggregation via the α5β1 Integrin Pathway and Paclitaxel Chemoresistance in Serous Epithelial Ovarian Carcinoma

被引:80
作者
Dong, Ying [1 ,2 ]
Tan, Olivia L. [1 ,2 ]
Loessner, Daniela [1 ,2 ]
Stephens, Carson [1 ,2 ]
Walpole, Carina [1 ,2 ]
Boyle, Glen M. [3 ]
Parsons, Peter G. [3 ]
Clements, Judith A. [1 ,2 ]
机构
[1] Queensland Univ Technol, Hormone Dependent Canc Program, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia
[2] Queensland Univ Technol, Sch Life Sci, Kelvin Grove, Qld 4059, Australia
[3] Queensland Inst Med Res, Drug Discovery Grp, Div Canc & Cell Biol, Herston, Qld 4006, Australia
基金
英国医学研究理事会;
关键词
CORNEUM CHYMOTRYPTIC ENZYME; CELL-ADHESION; CANCER CELLS; EXTRACELLULAR-MATRIX; SERINE PROTEASES; PROGNOSTIC VALUE; EXPRESSION; METASTASIS; DESQUAMATION; FIBRONECTIN;
D O I
10.1158/0008-5472.CAN-09-3415
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Kallikrein-related peptidase 7 (KLK7) is upregulated in epithelial ovarian carcinoma (EOC) with high levels correlated with poor prognosis. However, the mechanisms underlying this relationship and the role of KLK7 in EOC progression are unknown. We report that two different KLK7 transcripts, KLK7-253 and KLK7-181, are simultaneously expressed in high-grade serous EOC. Multicellular aggregates (MCA), which promote cell survival and chemoresistance, were observed in SKOV-3 cells stably overexpressing KLK7-253 in particular. Importantly, these MCAs invade into a monolayer of mesothelial cells and form cancer cell foci. Blocking MCA using antibodies against KLK7 and alpha(5)beta(1) and beta(1) integrins confirmed the involvement of KLK7 and integrin-regulated cell adhesion. Increased levels of alpha(5)/beta(1) integrins and enhanced attachment to fibronectin and vitronectin, which was blocked with an anti-beta(1) integrin antibody, were also observed. Finally, Western blot and immunohistochemistry showed higher KLK7 and alpha(5)/beta(1) integrin levels in serous EOC cells from ascites and tumor samples from chemotherapy nonresponders with short postsurvival times. Additionally, both KLK7-253 and KLK7-181 clones were more resistant to paclitaxel treatment in vitro. These findings suggest a mechanism for the association of high KLK7 levels with chemoresistance and poor prognosis for serous EOC patients by promotion of peritoneal dissemination and reinvasion via increased MCA and alpha(5)beta(1) integrin-dependent cell adhesion. Cancer Res; 70(7); 2624-33. (C) 2010 AACR.
引用
收藏
页码:2624 / 2633
页数:10
相关论文
共 47 条
[1]
Ovarian surface epithelium: Biology, endocrinology, and pathology [J].
Auersperg, N ;
Wong, AST ;
Choi, KC ;
Kang, SK ;
Leung, PCK .
ENDOCRINE REVIEWS, 2001, 22 (02) :255-288
[2]
BAST RC, 2009, NAT REV CANCER, V415, P28
[3]
Bhan V, 2004, ONCOL REP, V11, P893
[4]
The emerging roles of human tissue kallikreins in cancer [J].
Borgoño, CA ;
Diamandis, EP .
NATURE REVIEWS CANCER, 2004, 4 (11) :876-890
[5]
Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers [J].
Burleson, KM ;
Hansen, LK ;
Skubitz, APN .
CLINICAL & EXPERIMENTAL METASTASIS, 2004, 21 (08) :685-697
[6]
β1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids [J].
Casey, RC ;
Burleson, KM ;
Skubitz, KM ;
Pambuccian, SE ;
Oegema, TR ;
Ruff, LE ;
Skubitz, APN .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (06) :2071-2080
[7]
Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7 [J].
Caubet, C ;
Jonca, N ;
Brattsand, M ;
Guerrin, M ;
Bernard, D ;
Schmidt, R ;
Egelrud, T ;
Simon, M ;
Serre, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (05) :1235-1244
[8]
Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3 [J].
Chen, Mengqian ;
Fu, Ya-Yuan ;
Lin, Chen-Yong ;
Chen, Li-Mei ;
Chai, Karl X. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (07) :1133-1140
[9]
The tissue kallikrein family of serine proteases: Functional roles in human disease and potential as clinical [J].
Clements, JA ;
Willemsen, NM ;
Myers, SA ;
Dong, Y .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2004, 41 (03) :265-312
[10]
Dong Y, 2003, CLIN CANCER RES, V9, P1710